Search Results - Schallenkamp, John M

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer

    SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer by Chae, Young Kwang, Othus, Megan, Patel, Sandip Pravin, Wilkinson, Kelly J, Whitman-Purves, Emily M, Lea, Jayanthi, Schallenkamp, John M, Adra, Nabil, Appleman, Leonard J, Alden, Mitchell, Thomes Pepin, Jessica, Ellerton, John A, Poklepovic, Andrew, Walter, Adam, Rampurwala, Murtuza M, Robinson, William R, Kim, Hye Sung, Chung, Liam Il-Young, McLeod, Christine M, Lopez, Gabby, Chen, Helen X, Sharon, Elad, Streicher, Howard, Ryan, Christopher W, Blanke, Charles D, Kurzrock, Razelle

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Survivorship care plans: Is there buy‐in from community oncology providers?

    Survivorship care plans: Is there buy‐in from community oncology providers? by Salz, Talya, McCabe, Mary S., Onstad, Erin E., Baxi, Shrujal S., Deming, Richard L., Franco, Regina A., Glenn, Lyn A., Harper, Gregory R., Jumonville, Alcee J., Payne, Roxanne M., Peters, Elissa A., Salner, Andrew L., Schallenkamp, John M., Williams, Sheron R., Yiee, Kevin, Oeffinger, Kevin C.

    Published in Cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract CT161: A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the non-epithelial ovarian tumor cohort

    Abstract CT161: A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the non-epithelial ovarian tumor cohort by Chae, Young Kwang, Othus, Megan, Patel, Sandip Pravin, Wilkinson, Kelly J., Whitman-Purves, Emily M., Lea, Jayanthi, Schallenkamp, John M., Adra, Nabil, Appleman, Leonard J., Alden, Mitchell, Pepin, Jessica Thomes, Ellerton, John A., Poklepovic, Andrew, Walter, Adam, Rampurwala, Murtuza M., Robinson, William R., Chung, Liam Il-Young, McLeod, Christine M., Chen, Helen X., Sharon, Elad, Streicher, Howard, Ryan, Christopher W., Blanke, Charles D., Kurzrock, Razelle

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial

    Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial by Hwang, E. Shelley, Hyslop, Terry, Lynch, Thomas, Ryser, Marc D, Weiss, Anna, Wolf, Anna, Norris, Kelsey, Witten, Meredith, Grimm, Lars, Schnitt, Stuart, Badve, Sunil, Factor, Rachel, Frank, Elizabeth, Collyar, Deborah, Basila, Desiree, Pinto, Donna, Watson, Mark A, West, Robert, Davies, Louise, Donovan, Jenny L, Shimada, Ayako, Li, Yutong, Li, Yan, Bennett, Antonia V, Rosenberg, Shoshana, Marks, Jeffrey, Winer, Eric, Boisvert, Marc, Giuliano, Armando, Larson, Kelsey E, Yost, Kathleen, McAuliffe, Priscilla F, Krie, Amy, Tamirisa, Nina, Carey, Lisa A, Thompson, Alastair M, Partridge, Ann H

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: